Skip to main content
Erschienen in: Pathology & Oncology Research 1/2017

21.10.2016 | Letter to the Editor

USP9X, a Putative Tumor Suppressor Gene, Exhibits Frameshift Mutations in Colorectal Cancers

verfasst von: Yun Sol Jo, Min Sung Kim, Nam Jin Yoo, Sug Hyung Lee

Erschienen in: Pathology & Oncology Research | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: …
Literatur
1.
Zurück zum Zitat Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, Maecker H, O’Rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DC, Dixit VM (2010) Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463:103–107CrossRefPubMed Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, Maecker H, O’Rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DC, Dixit VM (2010) Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463:103–107CrossRefPubMed
2.
Zurück zum Zitat Kushwaha D, O’Leary C, Cron KR, Deraska P, Zhu K, D’Andrea AD, Kozono D (2015) USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1. Cancer Biol Ther 16:392–401CrossRefPubMedPubMedCentral Kushwaha D, O’Leary C, Cron KR, Deraska P, Zhu K, D’Andrea AD, Kozono D (2015) USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1. Cancer Biol Ther 16:392–401CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM, Initiative APCG, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486:266–270PubMedPubMedCentral Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM, Initiative APCG, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486:266–270PubMedPubMedCentral
4.
Zurück zum Zitat Oosterkamp HM, Hijmans EM, Brummelkamp TR, Canisius S, Wessels LF, Zwart W, Bernards R (2014) USP9X downregulation renders breast cancer cells resistant to tamoxifen. Cancer Res 74:3810–3820CrossRefPubMed Oosterkamp HM, Hijmans EM, Brummelkamp TR, Canisius S, Wessels LF, Zwart W, Bernards R (2014) USP9X downregulation renders breast cancer cells resistant to tamoxifen. Cancer Res 74:3810–3820CrossRefPubMed
5.
Zurück zum Zitat Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMed Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMed
6.
Zurück zum Zitat Yoo NJ, Kim HR, Kim YR, An CH, Lee SH (2012) Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60:943–952CrossRefPubMed Yoo NJ, Kim HR, Kim YR, An CH, Lee SH (2012) Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60:943–952CrossRefPubMed
7.
Zurück zum Zitat Murphy K, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8:305–311CrossRefPubMedPubMedCentral Murphy K, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8:305–311CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Oh HR, An CH, Yoo NJ, Lee SH (2015) Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers. Pathol Oncol Res 21:713–718CrossRefPubMed Oh HR, An CH, Yoo NJ, Lee SH (2015) Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers. Pathol Oncol Res 21:713–718CrossRefPubMed
9.
Zurück zum Zitat Harris DR, Mims A, Bunz F (2012) Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil. Cancer Biol Ther 13:1319–1324CrossRefPubMedPubMedCentral Harris DR, Mims A, Bunz F (2012) Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil. Cancer Biol Ther 13:1319–1324CrossRefPubMedPubMedCentral
Metadaten
Titel
USP9X, a Putative Tumor Suppressor Gene, Exhibits Frameshift Mutations in Colorectal Cancers
verfasst von
Yun Sol Jo
Min Sung Kim
Nam Jin Yoo
Sug Hyung Lee
Publikationsdatum
21.10.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 1/2017
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0140-z

Weitere Artikel der Ausgabe 1/2017

Pathology & Oncology Research 1/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.